Clinical Pharmacokinetics and Pharmacodynamics
Course, Master's level, 3FB225
Expand the information below to show details on how to apply and entry requirements.
Spring 2025
Spring 2025,
Uppsala, 100%, On-campus, The course will be taught in English, if needed
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 29 April 2025–8 June 2025
- Language of instruction
- The course will be taught in English, if needed
- Entry requirements
-
150 credits, including 120 credits in biomedicine, biology, pharmaceutical sciences, chemistry and/or natural sciences/technology. Earlier studies should include 7.5 credits of pharmacokinetics and 7.5 credits of pharmacology.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 October 2024
- Application code
- UU-89215
Admitted or on the waiting list?
- Registration period
- 15 April 2025–28 April 2025
- Information on registration from the department
Spring 2025
Spring 2025,
Uppsala, 100%, On-campus, The course will be taught in English, if needed
For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 29 April 2025–8 June 2025
- Language of instruction
- The course will be taught in English, if needed
- Entry requirements
-
150 credits, including 120 credits in biomedicine, biology, pharmaceutical sciences, chemistry and/or natural sciences/technology. Earlier studies should include 7.5 credits of pharmacokinetics and 7.5 credits of pharmacology.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
- Registration period
- 15 April 2025–28 April 2025
- Information on registration from the department
Expand the information below to show details on how to apply and entry requirements.
Spring 2026
Spring 2026,
Uppsala, 100%, On-campus, The course will be taught in English, if needed
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 4 May 2026–7 June 2026
- Language of instruction
- The course will be taught in English, if needed
- Entry requirements
-
150 credits, including 120 credits in biomedicine, biology, pharmaceutical sciences, chemistry and/or natural sciences/technology. Earlier studies should include 7.5 credits of pharmacokinetics and 7.5 credits of pharmacology.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 October 2025
- Application code
- UU-89215
Admitted or on the waiting list?
- Registration period
- 24 April 2026–1 May 2026
- Information on registration from the department
Spring 2026
Spring 2026,
Uppsala, 100%, On-campus, The course will be taught in English, if needed
For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 4 May 2026–7 June 2026
- Language of instruction
- The course will be taught in English, if needed
- Entry requirements
-
150 credits, including 120 credits in biomedicine, biology, pharmaceutical sciences, chemistry and/or natural sciences/technology. Earlier studies should include 7.5 credits of pharmacokinetics and 7.5 credits of pharmacology.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
- Registration period
- 24 April 2026–1 May 2026
- Information on registration from the department
About the course
The course gives an understanding of how pharmacokinetic (PK) and pharmacodynamic (PD) information can be applied in clinical drug development. In addition, the course gives you sufficient knowledge to be able to contribute to the planning, design and analysis of clinical studies, from a PK and PD perspective.
Teaching and training are given in data analysis, study design, simulations of clinical trials and oral presentation. The course also includes topics such as disease progression, drug effects on disease progression, and PD models that describe these processes. Software for data analysis and simulation of clinical trials and result presentations are applied during the course.
The main part of the work is performed in groups.